Clinical and microbiological effectiveness of limosilactobacillus reuteri in supportive periodontal therapy: randomized clinical trial.
- 2025-08-26
- RCT
- Clinical oral investigations 29(9)
- Magda Mensi
- Eleonora Scotti
- Silvia Marchetti
- Annamaria Sordillo
- Gianluca Garzetti
- Stefano Calza
- Mark J Buijs
- Egija Zaura
- Bernd W Brandt
- PubMed: 40856866
- DOI: 10.1007/s00784-025-06508-w
- High evidence
- Clinical
Both groups showed a significant decrease in PPD, BOP, CAL, and number/percentage of residual pockets compared to baseline. However, no inter-group differences were noted.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 3 weeks of bi-daily supplementation with lozenges containing probiotic (specific CFU not stated in abstract)